RXO, Inc. (RXO) Stock Forecast
RXO analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.28 / 5 from 18 analysts
- Price target
- $27.96 average of analyst targets
- Upside to target
- −2.2% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $0.08
- 52-week range
- $10.48 – $29.30
RXO analyst ratings
18 analystsNumber of analysts at each rating.
RXO price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
RXO earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.07 | $0.05 | $0.09 | $0.01 | +644.7% | 19 |
| Current fiscal year (2026) | $0.14 | $0.10 | $0.18 | −$0.04 | +458.3% | 19 |
| Next fiscal year (2027) | $0.65 | $0.45 | $0.87 | $0.14 | +354.7% | 20 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
RXO revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.82B | $1.74B | $1.92B | +27.9% | 16 |
| Current fiscal year (2026) | $6.85B | $6.68B | $7.04B | +19.4% | 19 |
| Next fiscal year (2027) | $7.55B | $6.85B | $8.06B | +10.1% | 19 |
RXO EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
RXO revenue: reported and forecast
RXO EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.04 | $0.06 | $0.07 | $0.07 | $0.07 | +101.4% | 9 up · 0 down |
| Current fiscal year (2026) | $0.07 | $0.12 | $0.12 | $0.14 | $0.14 | +108.6% | 9 up · 0 down |
| Next fiscal year (2027) | $0.53 | $0.61 | $0.62 | $0.64 | $0.65 | +21.8% | 8 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
RXO earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; RXO beat in 8 of 12.
What analysts expect from RXO
18 analysts cover RXO; their consensus rating is hold (3.28 on a 1–5 scale, where 5 is a strong buy). The average price target is $27.96, 2.2% below the latest close of $28.60. Analysts expect earnings of $0.14 per share for 2026, +458.3% from a year earlier. For 2027 the average estimate is $0.65 per share on revenue of $7.5 billion. RXO beat the EPS estimate in 8 of the last 12 quarters.
Related: RXO income statement, RXO key metrics, RXO chart. See the RXO stock overview for the latest quote and news.
RXO forecast FAQ
What is RXO's price target?
The average analyst price target for RXO is $27.96, 2.2% below the latest close of $28.60.
Is RXO a buy, hold or sell?
Of 18 analysts covering RXO, 2 rate it a strong buy, 1 a buy, 15 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is RXO's EPS forecast?
Analysts forecast $0.14 per share for 2026 (range $0.10 to $0.18); for 2027 the estimate is $0.65.
What is RXO's revenue forecast?
The average revenue estimate for 2026 is $6.9 billion, growth of 19.4%; for 2027 it is $7.5 billion.
When does RXO report earnings?
RXO is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens; the EPS estimate is $0.08.
Does RXO usually beat earnings estimates?
RXO reported EPS at or above the analyst estimate in 8 of the last 12 quarters.